OncLive TV

OncLive® TV is an editorial video program featuring one-on-one live and/or virtual interviews with key opinion leaders in the oncology field for their expert insight on breaking news, regulatory updates, practice-changing data presented at medical meetings, and other pivotal topics in a cancer specialty, including breast cancer, lung cancer, genitourinary cancers, gastrointestinal cancers, gynecologic cancers, and hematologic cancers.

Dr. Gafita on the Rationale to Evaluate 177Lu-PSMA-617 in mCRPC

July 17th 2020

Andrei Gafita, MD, discusses the rationale to evaluate lutetium-177 PSMA-617 in metastatic castration-resistant prostate cancer.

Dr. Shaughnessy on Available CAR T-Cell Therapies in R/R Hematologic Malignancies

July 17th 2020

Paul J. Shaughnessy, MD, discusses the available CAR T-cell therapies for relapsed/refractory hematologic malignancies.

Dr. Mesa on Recent Data With Momelotinib in MPNs and Myelofibrosis

July 17th 2020

Ruben A. Mesa, MD, director of the Mays Cancer Center at UT Health San Antonio MD Anderson Cancer Center, discusses recent data with momelotinib in myelofibrosis.

Dr. Tolaney on Deescalating Therapy in Stage I HER2+ Breast Cancer

July 17th 2020

Sara M. Tolaney, MD, MPH, discusses appropriately deescalating treatment to reduce toxicities in stage I HER2-positive breast cancer.

Dr. Kumar on the Rationale for the ENDURANCE Trial in Multiple Myeloma

July 17th 2020

Shaji K. Kumar, MD, discusses the rationale for conducting the phase 3 ENDURANCE trial in newly diagnosed multiple myeloma.

Dr. Abou-Alfa on Remaining Questions With Infigratinib in FGFR2+ Cholangiocarcinoma

July 16th 2020

Ghassan K. Abou-Alfa, MD, discusses the questions that remain with infigratinib in advanced cholangiocarcinoma with FGFR2 gene fusions/translocations.

Dr. Bach on Examining ctDNA in CRC

July 16th 2020

Sander Bach, MD, PhD, discusses research examining circulating tumor DNA in colorectal cancer.

Dr. Czerniecki on the Importance of Multidisciplinary Efforts for Breast Cancer Brain/CNS Metastases

July 16th 2020

Brian Czerniecki, MD, PhD, discusses the importance of utilizing a multidisciplinary effort to treat patients with breast cancer who develop brain or central nervous system metastases.

Dr. Daver on the Advancing Treatment Landscape in AML

July 16th 2020

Naval G. Daver, MD, discusses the advancing treatment landscape in both acute myeloid leukemia and acute lymphoblastic leukemia.

Dr. Gilbert on the Safety Profile of Mirvetuximab Soravtansine/Bevacizumab in Ovarian Cancer

July 16th 2020

Lucy Gilbert, MD, MSc, discusses the safety profile of mirvetuximab soravtansine in combination with bevacizumab in patients with platinum-agnostic ovarian cancer.

Dr. Lin on the Treatment Landscape in HER2+ Metastatic Breast Cancer

July 16th 2020

Nancy U. Lin, MD, discusses the treatment landscape in HER2-positive metastatic breast cancer.

Dr. Czerniecki on Treatment Options for Patients With HER2+ Brain Metastases

July 15th 2020

Brian Czerniecki, MD, PhD, discusses treatment options for patients with HER2-positive breast cancer who have brain metastases.

Dr. Daver on the Utility of Maintenance Therapy in AML

July 15th 2020

Naval G. Daver, MD, discusses the utility of maintenance chemotherapy in acute myeloid leukemia.

Dr. Slomovitz on the Role of Surgery in Endometrial Cancer

July 15th 2020

Brian M. Slomovitz, MD, discusses the role of surgery in women with endometrial cancer.

Dr. Ghia on the Shift From Chemotherapy to Novel Agents in CLL

July 15th 2020

Paolo Ghia, MD, PhD, discusses how use the of chemotherapy is decreasing in favor of novel agents in chronic lymphocytic leukemia.

Dr. Ahmed on Key Strategies for Managing Breast Cancer Brain Metastases

July 15th 2020

Kamran A. Ahmed, MD, discusses key strategies to manage patients with breast cancer and brain metastases.

Dr. Luke on Future Research With T-Cell Therapy in Melanoma

July 15th 2020

Jason J. Luke, MD, FACP, discusses the future of T-cell therapy in melanoma.

Dr. Davids on the Potential Utility of Ibrutinib/Umbralisib in MCL and CLL

July 15th 2020

Matthew S. Davids, MD, MMSc, discusses the potential utility of ibrutinib in combination with umbralisib in patients with mantle cell lymphoma or relapsed/refractory chronic lymphocytic leukemia.

Dr. Bach Discusses Ongoing Research With ctDNA in CRC

July 15th 2020

Sander Bach, MD, PhD, discusses ongoing research with circulating tumor DNA in colorectal cancer.

Dr. Rana on Using Age at Diagnosis to Guide the Utility of Genetic Testing in Prostate Cancer

July 14th 2020

Huma Q. Rana, MD, MPH, discusses the use of age at diagnosis to guide the utility of genetic testing in men with prostate cancer.